1
|
Shrikhande B, Khosla J, Al-Kindi S, Asad ZUA, Al-Juhaishi T. Cardiac Graft Versus Host Disease: A Rare or Underrecognized Pathology? Curr Probl Cardiol 2023; 48:101807. [PMID: 37244510 DOI: 10.1016/j.cpcardiol.2023.101807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2023] [Accepted: 05/13/2023] [Indexed: 05/29/2023]
Abstract
Allogeneic hematopoietic stem cell transplantation is a potentially curative procedure for a variety of hematologic and immunologic disorders. Despite the powerful therapeutic potential, both acute, and chronic toxicities including graft versus host disease (GVHD) and cardiovascular disease can lead to significant short- and long-term morbidity and mortality. While GVHD can affect any organ, cardiac involvement is rarely described in the literature. In this review, we review available literature, and allude to pathophysiology and therapeutic approaches in cardiac GVHD.
Collapse
Affiliation(s)
- Bhushan Shrikhande
- Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK
| | - Jagjit Khosla
- Department of Cardiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK
| | - Sadeer Al-Kindi
- Harrington Heart and Vascular Institute, University Hospitals and Case Western Reserve University, Cleveland, OH
| | - Zain Ul Abideen Asad
- Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK
| | - Taha Al-Juhaishi
- Department of Medicine, Section of Hematology and Medical Oncology, OU Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
| |
Collapse
|
2
|
Sumi M, Kitahara M, Shishido T, Kazumoto H, Uematsu N, Kirihara T, Sato K, Ueki T, Hiroshima Y, Shimizu K, Kobayashi H. Myocarditis with Advanced Atrioventricular Block after Allogeneic Stem Cell Transplantation: A Case Report and Literature Review. Intern Med 2020; 59:113-118. [PMID: 31462594 PMCID: PMC6995704 DOI: 10.2169/internalmedicine.3322-19] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
A 51-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia underwent a second cord blood transplantation followed by maintenance therapy with interferon-α. After 33 months, she developed cardiogenic shock caused by advanced atrioventricular block. Laboratory tests revealed increased myocardium enzymes, and ultrasonic cardiography demonstrated mild thickening of the left ventricular wall. She was diagnosed with myocarditis and successfully treated using prednisolone. Myocarditis after allogeneic stem cell transplantation is a rare but potentially fatal complication. However, it is important for physicians to be aware of this complication because all of the symptoms may be reversed with immunosuppressive treatment.
Collapse
Affiliation(s)
- Masahiko Sumi
- Department of Hematology, Nagano Red Cross Hospital, Japan
| | - Mari Kitahara
- Department of Hematology, Nagano Red Cross Hospital, Japan
| | | | | | - Nozomu Uematsu
- Department of Hematology, Nagano Red Cross Hospital, Japan
| | | | - Keijiro Sato
- Department of Hematology, Nagano Red Cross Hospital, Japan
| | | | - Yuki Hiroshima
- Department of Hematology, Nagano Red Cross Hospital, Japan
| | | | | |
Collapse
|
3
|
Zinter MS, Barrows BD, Ursell PC, Kowalek K, Kalantar K, Cambronero N, DeRisi JL, Oishi P, Dvorak CC. Extracorporeal life support survival in a pediatric hematopoietic cellular transplant recipient with presumed GvHD-related fulminant myocarditis. Bone Marrow Transplant 2017; 52:1330-1333. [PMID: 28581474 PMCID: PMC5589976 DOI: 10.1038/bmt.2017.114] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- M S Zinter
- University of California, Benioff Children's Hospital, San Francisco, CA, USA.,Department of Pediatrics, University of California, Division of Critical Care Medicine, San Francisco, CA, USA
| | - B D Barrows
- University of California, Benioff Children's Hospital, San Francisco, CA, USA.,Department of Pathology, University of California, San Francisco, CA, USA
| | - P C Ursell
- University of California, Benioff Children's Hospital, San Francisco, CA, USA.,Department of Pathology, University of California, San Francisco, CA, USA
| | - K Kowalek
- University of California, Benioff Children's Hospital, San Francisco, CA, USA.,Department of Pediatrics, University of California, Division of Critical Care Medicine, San Francisco, CA, USA
| | - K Kalantar
- Department of Biochemistry and Biophysics, University of California, San Francisco, CA, USA
| | - N Cambronero
- University of California, Benioff Children's Hospital, San Francisco, CA, USA.,Department of Surgery, University of California, Division of Pediatric Cardiothoracic Surgery, San Francisco, CA, USA
| | - J L DeRisi
- Department of Biochemistry and Biophysics, University of California, San Francisco, CA, USA.,Chan Zuckerberg Biohub, San Francisco, CA, USA
| | - P Oishi
- University of California, Benioff Children's Hospital, San Francisco, CA, USA.,Department of Pediatrics, University of California, Division of Critical Care Medicine, San Francisco, CA, USA
| | - C C Dvorak
- University of California, Benioff Children's Hospital, San Francisco, CA, USA.,Department of Pediatrics, University of California, Division of Allergy, Immunology, and Blood and Marrow Transplantation, San Francisco, CA, USA
| |
Collapse
|